CBL-514

· Caliway Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for CBL-514, covering 2021-01-08 to 2026-07-09. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2) [Phase 2]